Johannes Jacob Pieter Kastelein

Director & Chief Scientific Officer

Director & Chief Scientific Officer at NewAmsterdam Pharma Co N.V., filing insider transactions between 2026-02-20 and 2026-03-09.

Total Purchases

—

0 transactions

Total Sales

$10.7M

5 transactions

Companies Traded

5 total filings

Active Since

2026-02-20

Last: 2026-03-09

Companies

NewAmsterdam Pharma Co N.V.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-09	NAMS	Sale	101.4K	$30.29	$3.1M	69.3K	SEC ↗
2026-03-06	NAMS	Sale	94.1K	$30.32	$2.9M	69.3K	SEC ↗
2026-03-05	NAMS	Sale	104.5K	$30.30	$3.2M	69.3K